Analytical and Chemical Knowledge Management Software for Drug Metabolism Science
Poster May 05, 2011
Graham A. McGibbon, Karim Kassam, and Susan Ling
For over 16 years, ACD/Labs has facilitated discovery by offering cutting edge scientific software for the management of chemical structures, reactions, analytical data, and prediction of properties.
This poster describes a unique enterprise software platform that enables effective management and dissemination biotransformation pathways. This software accommodates discrete or indeterminate structures, associated analytical data, and supporting information. The information is highly searchable and can be integrated with existing informatics infrastructure. It can also be extended to incorporate the many property prediction modules offered by ACD/Labs to better anticipate and avoid unwanted liabilities.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
OTHER POSTERS
Assessment of Oral LISPRO Treatment in Ameliorating Amyloid and Tau Pathology in Transgenic Alzheimer’s Mice Model
PosterIonic co-crystals of lithium salicylate with organic proline (LISPRO) showed better safety and pharmacokinetic profile of lithium in plasma and brain of wild-type and transgenic Alzheimer mice model compared to lithium salts.
READ MORE
Investigating the Effects of Fructose Consumption and Inadequate Copper Intake on Nonalcoholic Fatty Liver Disease
PosterMetabolomics is a viable method for identifying compounds associated with NAFLD. In this investigation, high-quality data facilitate the identification of key metabolites differentiating normal versus diseased species.
READ MORE
CiPA Phase 2 Study: validation of an automated microelectrode array (MEA) assay of hiPSC-derived cardiomyocyte electrophysiology for cardiac safety evaluation
PosterThese results support the use of hSC-CM and MEA technology for preclinical assessment of proarrhythmic risk within the proposed CiPA paradigm, and, more generally, demonstrate that automation of the CM-MEA assay can achieve high reliability and throughput for cardiac risk assessment in vitro.
READ MOREComments | 0 ADD COMMENT
Like what you just read? You can find similar content on the communities below.
Drug Discovery Proteomics & MetabolomicsTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBO Workshop: Integrating Systems Biology: From Networks to Mechanisms to Models
Apr 15 - Apr 17, 2018
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018
Login
You must be logged in to post a comment.